A Phase 2 Randomized, Open-Label, Exploratory Trial of GS-5885, GS-9451 with Peginterferon Alfa 2a (PEG) and Ribavirin (RBV) in Treatment-Naive Subjects with Chronic Genotype 1 Hepatitis C Virus ..

Lubel, John (Primary Chief Investigator (PCI))

Eastern Health Clinical School
Eastern Clinical Research Unit

Project: Research

Project Details

Project Description

Title: Trial of GS-5885, GS-9451 with Peginterferon Alfa 2a (PEG) and Ribavirin (RBV) in Treatment-Naive Subjects with Chronic Genotype 1 Hepatitis C Virus Infection and IL28B CC Genotype

Status	Finished
Effective start/end date	13/01/12 → 13/01/14

View all

View less